CA Stock MarketDetailed Quotes

NAV Navco Pharmaceuticals Inc

Watchlist
  • 0.015
  • 0.0000.00%
15min DelayMarket Closed Dec 17 16:00 ET
856.04KMarket Cap-0.75P/E (TTM)

Navco Pharmaceuticals Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(FY)Sep 30, 2022
(Q1)Sep 30, 2022
(Q4)Jun 30, 2022
(Q3)Mar 31, 2022
(Q2)Dec 31, 2021
(Q1)Sep 30, 2021
(FY)Jun 30, 2021
(Q4)Jun 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
77.94%-259
-154.32%-21.44K
94.38%-4.54K
0.00%-258
99.07%-407
11.40%-1.17K
61.50%-8.43K
98.10%-258
-67.57%-80.71K
-516.21%-43.9K
Net income from continuing operations
212.92%8.31K
76.54%-5.86K
-527.86%-465.13K
85.37%-2.05K
-48.88%-47.38K
57.52%-7.36K
-37.12%-24.97K
-107.59%-13.98K
-49.47%-74.08K
-121.68%-31.83K
Depreciation and amortization
----
----
--43.81K
----
----
----
----
----
----
----
Other non cashItems
15.38%-1.35K
15.90%-1.35K
373.70%14.94K
-6.20%-1.68K
-6.17%-1.64K
-6.20%-1.59K
-6.15%-1.6K
-73.82%-1.58K
---5.46K
---1.54K
Change In working capital
-192.82%-7.22K
-178.44%-14.23K
34,503.60%401.83K
-77.35%3.47K
561.44%48.61K
-55.55%7.77K
933.30%18.14K
357.25%15.3K
-183.55%-1.17K
-245.66%-10.53K
-Change in inventory
----
----
--6.01K
----
----
----
----
----
----
----
-Change in payables and accrued expense
-192.82%-7.22K
-178.44%-14.23K
36,180.31%421.42K
-77.35%3.47K
561.44%48.61K
-46.60%7.77K
2,296.43%18.14K
357.25%15.3K
-94.02%-1.17K
-245.66%-10.53K
-Change in other working capital
----
----
---25.59K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
77.94%-259
-154.32%-21.44K
94.38%-4.54K
0.00%-258
99.07%-407
11.40%-1.17K
61.50%-8.43K
98.10%-258
-67.57%-80.71K
-516.21%-43.9K
Investing cash flow
Cash flow from continuing investing activities
0
Net PPE purchase and sale
----
----
--0
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
----
----
--0
----
----
----
----
----
----
----
Financing cash flow
Cash flow from continuing financing activities
0
0
102.26%2K
20K
0
0
0
0
-449.26%-88.5K
0
Net issuance payments of debt
--0
--0
102.03%2K
--20K
--0
--0
--0
--0
-488.73%-98.5K
--0
Net common stock issuance
----
----
--0
----
----
----
----
----
----
----
Proceeds from stock option exercised by employees
----
----
----
----
----
----
----
----
--10K
--0
Cash from discontinued financing activities
Financing cash flow
--0
--0
102.26%2K
--20K
--0
--0
--0
--0
-449.26%-88.5K
--0
Net cash flow
Beginning cash position
-96.92%104
82.41%21.54K
-97.75%4.07K
-85.09%1.8K
-93.96%3.38K
-94.10%3.38K
-82.93%11.81K
-93.34%12.07K
-11.18%181.28K
-70.29%55.97K
Current changes in cash
---259
-154.32%-21.44K
98.50%-2.54K
7,751.94%19.74K
96.40%-1.58K
--0
29.14%-8.43K
99.77%-258
-641.27%-169.21K
-516.21%-43.9K
End cash Position
-104.59%-155
-96.92%104
-87.28%1.54K
82.41%21.54K
-85.09%1.8K
-93.96%3.38K
-94.10%3.38K
-82.93%11.81K
-93.34%12.07K
-93.34%12.07K
Free cash from
77.94%-259
-154.32%-21.44K
94.38%-4.54K
0.00%-258
99.07%-407
11.40%-1.17K
61.50%-8.43K
98.10%-258
-67.57%-80.71K
-516.21%-43.9K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Mar 31, 2023(Q2)Dec 31, 2022(FY)Sep 30, 2022(Q1)Sep 30, 2022(Q4)Jun 30, 2022(Q3)Mar 31, 2022(Q2)Dec 31, 2021(Q1)Sep 30, 2021(FY)Jun 30, 2021(Q4)Jun 30, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 77.94%-259-154.32%-21.44K94.38%-4.54K0.00%-25899.07%-40711.40%-1.17K61.50%-8.43K98.10%-258-67.57%-80.71K-516.21%-43.9K
Net income from continuing operations 212.92%8.31K76.54%-5.86K-527.86%-465.13K85.37%-2.05K-48.88%-47.38K57.52%-7.36K-37.12%-24.97K-107.59%-13.98K-49.47%-74.08K-121.68%-31.83K
Depreciation and amortization ----------43.81K----------------------------
Other non cashItems 15.38%-1.35K15.90%-1.35K373.70%14.94K-6.20%-1.68K-6.17%-1.64K-6.20%-1.59K-6.15%-1.6K-73.82%-1.58K---5.46K---1.54K
Change In working capital -192.82%-7.22K-178.44%-14.23K34,503.60%401.83K-77.35%3.47K561.44%48.61K-55.55%7.77K933.30%18.14K357.25%15.3K-183.55%-1.17K-245.66%-10.53K
-Change in inventory ----------6.01K----------------------------
-Change in payables and accrued expense -192.82%-7.22K-178.44%-14.23K36,180.31%421.42K-77.35%3.47K561.44%48.61K-46.60%7.77K2,296.43%18.14K357.25%15.3K-94.02%-1.17K-245.66%-10.53K
-Change in other working capital -----------25.59K----------------------------
Cash from discontinued investing activities
Operating cash flow 77.94%-259-154.32%-21.44K94.38%-4.54K0.00%-25899.07%-40711.40%-1.17K61.50%-8.43K98.10%-258-67.57%-80.71K-516.21%-43.9K
Investing cash flow
Cash flow from continuing investing activities 0
Net PPE purchase and sale ----------0----------------------------
Cash from discontinued investing activities
Investing cash flow ----------0----------------------------
Financing cash flow
Cash flow from continuing financing activities 00102.26%2K20K0000-449.26%-88.5K0
Net issuance payments of debt --0--0102.03%2K--20K--0--0--0--0-488.73%-98.5K--0
Net common stock issuance ----------0----------------------------
Proceeds from stock option exercised by employees ----------------------------------10K--0
Cash from discontinued financing activities
Financing cash flow --0--0102.26%2K--20K--0--0--0--0-449.26%-88.5K--0
Net cash flow
Beginning cash position -96.92%10482.41%21.54K-97.75%4.07K-85.09%1.8K-93.96%3.38K-94.10%3.38K-82.93%11.81K-93.34%12.07K-11.18%181.28K-70.29%55.97K
Current changes in cash ---259-154.32%-21.44K98.50%-2.54K7,751.94%19.74K96.40%-1.58K--029.14%-8.43K99.77%-258-641.27%-169.21K-516.21%-43.9K
End cash Position -104.59%-155-96.92%104-87.28%1.54K82.41%21.54K-85.09%1.8K-93.96%3.38K-94.10%3.38K-82.93%11.81K-93.34%12.07K-93.34%12.07K
Free cash from 77.94%-259-154.32%-21.44K94.38%-4.54K0.00%-25899.07%-40711.40%-1.17K61.50%-8.43K98.10%-258-67.57%-80.71K-516.21%-43.9K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.